538965.BO Net Margin

As of 2025-07-10, the Net Margin of Concord Drugs Ltd (538965.BO) is 0.7%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

538965.BO Net Margin - Historical Value
DateValue
2025-03-31 0.7%
2024-03-31 1.1%
2023-03-31 1.9%
2022-03-31 2.7%
2021-03-31 6.4%
2020-03-31 0.6%
2019-12-31 0.4%
2019-09-30 0.4%
2019-06-30 1%
2019-03-31 0.4%
538965.BO Net Margin - Peers Comparison